# JNPMEDI Partners

> JNPMEDI Partners is a VC fund in Incheon backing Wellness and Health Care. See 2 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Incheon, South Korea
- Total investments: 2
- Last investment: Sep 2025
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/jnpmedi
- Website: https://en.jnpmedipartners.com

JNPMEDI Partners is a VC fund in Incheon focused on Wellness and Health Care. JNPMEDI Partners links investors and life sciences companies looking for funding, giving investors clear performance reports and opportunities for companies to obtain capital.

## Contacts

5 contacts available for JNPMEDI Partners. Shizune tracks 1 team members at JNPMEDI Partners. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/jnpmedi-partners?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Wellness | 1 | 50% |
| Health Care | 1 | 50% |
| Life Science | 1 | 50% |
| Biotechnology | 1 | 50% |
| Medical Device | 1 | 50% |

6 industries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Kwunho Jeong | CEO | 0 | https://shizune.co/investors/profile/kwunho-jeong |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Readycure | Readycure is developing an innovative solution focused on non-drug treatments by combining digital X-ray technology with artificial intelligence. This groundbreaking approach aims to provide effective healthcare solutions without relying on traditional medications. By leveraging AI to analyze digital X-ray images, Ready Cure’s solution offersadvanced diagnostic capabilities and personalized treatment options. This innovative technology has the potential to improve patient outcomes, reduce reliance on pharmaceuticals, and transform healthcare practices, particularly in areas that can benefit from non-invasive treatments. | $35.9K | Seed | Sep 23, 2025 | http://www.ready-cure.com |
| Kim Cell & Gene | Kimcell & Gene is creating antibody treatments that target resistance. |  | Seed | Jun 20, 2025 | https://kimcellgene.com |

2 of 2 investments shown.

## Co-investors
- [Yuhan Corporation](https://shizune.co/investors/profile/yuhan-corporation) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Strong Ventures](https://shizune.co/investors/profile/strong-ventures) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund
- [Kakao Ventures](https://shizune.co/investors/profile/kakao-ventures) — VC Fund

## Featured in investor lists
- [Life Science VC Funds in South Korea](https://shizune.co/investors/life-science-vc-funds-south-korea)

## FAQ

### What does JNPMEDI Partners invest in?

JNPMEDI Partners invests primarily in Wellness, Health Care and Life Science startups, most often at Seed stage. Most of the 2 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact JNPMEDI Partners?

Public channels for JNPMEDI Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at JNPMEDI Partners?

The team at JNPMEDI Partners includes Kwunho Jeong (CEO). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co